Health
Novel protection pathway makes cells resistant to viral infection – Drug Target Review
Researchers reveal that activating the MHC class II transactivator (CIITA) and CD74 genes protected cells against infection by Ebola and SARS-CoV-2.
Posted: 28 August 2020 | Hannah Balfour (Drug Target Review) | No comments yet
Researchers reveal that activating the MHC class II transactivator (CIITA) and CD74 genes protected cells against infection by Ebola and SARS-CoV-2.
Researchers have discovered a new cellular protection mechanism which they demonstrated can prevent viruses, including Ebola and coronaviruses like SARS-CoV-2, from infecting cells. According to the collaborators, the new understanding surrounding cellular mechanisms in…
-
Business23 hours agoHow to boost your superannuation in the final 10 years before retirement
-
Noosa News23 hours agoBec Mac wants to wake up the world’s earliest-rising city
-
Business22 hours ago3 unstoppable trends driving ASX stocks higher
-
Noosa News22 hours agoCockchafer worm wreaking havoc on West Australian grain crops